| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9814690 | GALDERMA LABS | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec, 2022
(1 year, 4 months ago) | |
| US8809305 | GALDERMA LABS | Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris |
Dec, 2022
(1 year, 4 months ago) | |
| US8445543 | GALDERMA LABS | Combinations of adapalene and benzoyl peroxide for treating acne lesions |
Dec, 2022
(1 year, 4 months ago) | |
| US8909305 | GALDERMA LABS | Method and system for activating an application on a mobile device |
Dec, 2022
(1 year, 4 months ago) | |
| US8785420 | GALDERMA LABS | Combination/association of adapalene and benzoyl peroxide for treating acne lesions |
Dec, 2022
(1 year, 4 months ago) | |
| US8936800 | GALDERMA LABS | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec, 2022
(1 year, 4 months ago) | |
| US8729127 | GALDERMA LABS | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(1 year, 1 month ago) | |
| US9381179 | GALDERMA LABS | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(1 year, 1 month ago) | |
| US8703820 | GALDERMA LABS | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(1 year, 1 month ago) | |
| US9387187 | GALDERMA LABS | Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(1 year, 1 month ago) | |
Epiduo Forte is owned by Galderma Labs.
Epiduo Forte contains Adapalene; Benzoyl Peroxide.
Epiduo Forte has a total of 10 drug patents out of which 10 drug patents have expired.
Expired drug patents of Epiduo Forte are:
- US9814690
- US8809305
- US8445543
- US8909305
- US8785420
- US8936800
- US8729127
- US9381179
- US8703820
- US9387187
Epiduo Forte was authorised for market use on 15 July, 2015.
Epiduo Forte is available in gel;topical dosage forms.
Epiduo Forte can be used as treatment of acne.
The generics of Epiduo Forte are possible to be released after 12 March, 2023.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jul 15, 2018 |
Drugs and Companies using ADAPALENE; BENZOYL PEROXIDE ingredient
Market Authorisation Date: 15 July, 2015
Treatment: Treatment of acne
Dosage: GEL;TOPICAL
EPIDUO FORTE family patents
